Skip to main content
logo
Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
2.260
-0.070 (-3.00%)
At close: Jul 13, 2026, 4:00 PM EDT
2.240
-0.020 (-0.88%)
After-hours: Jul 13, 2026, 7:35 PM EDT

Compass Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-68.17-66.49-49.38-42.49-39.23-82.18
Depreciation & Amortization
0.150.280.590.70.780.57
Stock-Based Compensation
10.938.378.566.125.334.03
Other Adjustments
-0.58-0.48-0.49-2.040.2551.68
Changes in Accounts Payable
-0.67-0.66-1.840.712.52-0.19
Changes in Accrued Expenses
-5.215.13.77-9.182.927.02
Changes in Other Operating Activities
10.364.75-6.075.56-6.69-0.58
Operating Cash Flow
-53.2-49.14-44.86-40.62-34.13-19.67
Capital Expenditures
-0.09-0.03-0.04-0.03-0.21-1.57
Sale of Property, Plant & Equipment
----0.180.12
Purchases of Investments
-214.54-194.56-88.16-155.42-200.12-
Proceeds from Sale of Investments
148.16101.28134.97182.4148.96-
Other Investing Activities
------0.32
Investing Cash Flow
-66.47-93.3146.7726.97-151.2-1.77
Long-Term Debt Repaid
------9.38
Net Long-Term Debt Issued (Repaid)
------9.38
Issuance of Common Stock
-139.2718.113.1976.25128.27
Repurchase of Common Stock
-0.7-1.03-0.23-0.16--
Net Common Stock Issued (Repurchased)
-0.7138.2517.883.0376.25128.27
Other Financing Activities
--8.64-0.54-0.09-0.5-0.28
Financing Cash Flow
133.79129.6117.342.9475.76118.61
Net Cash Flow
14.12-12.8419.26-10.72-109.5797.18
Free Cash Flow
-53.29-49.17-44.9-40.65-34.34-21.23
FCF Margin
---5282.24%---
Free Cash Flow Per Share
-0.31-0.31-0.33-0.32-0.33-0.34
Levered Free Cash Flow
-63.64-57.06-52.97-44.73-39.92-86.31
Unlevered Free Cash Flow
-70.64-136.25-117.7-52.6-42.35-76.64
SEC Filings: 10-K · 10-Q